Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer

BMC Urology

Volumn 12, Issue , 2012, Pages

  Rivas, Alexis ^a,b   Burzio, Verónica ^a,b   Landerer, Eduardo ^b,c   Borgna, Vincenzo ^a,b   Gatica, Sebastian ^a   Ávila, Rodolfo ^a,b   López, Constanza ^a   Villota, Claudio ^a,b   De La Fuente, Rodrigo ^d   Echenique, Javiera ^a   Burzio, Luis O ^a,b   Villegas, Jaime ^a,b  

^a Fundacion Ciencia para la Vida   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c Hospital Exequiel González Cortés   (Chile)

^d HOSPITAL BARROS LUCO TRUDEAU   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; LONG UNTRANSLATED RNA; MITOCHONDRIAL RNA;

ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; CANCER GRADING; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PROSTATE CARCINOMA; PROTEIN EXPRESSION; URINALYSIS; URINE LEVEL;

CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PILOT PROJECTS; RNA; RNA, LONG UNTRANSLATED; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS; URINE;

EID: 84871105782     PISSN: None     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-12-37     Document Type: Article

References (30)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Bladder cancer. Kaufman DS, Shipley WU, Feldman AS, Lancet 2009 374 239 249 10.1016/S0140-6736(09)60491-8 19520422
3. Bladder cancer biomarkers and their role in surveillance and screening. Van Tilborg AA, Bangma CH, Zwarthoff EC, Int J Urol 2009 16 23 30 10.1111/j.1442-2042.2008.02174.x 19120523
4. The clinical value of urinary cytology: 12 years of experience with 615 patients. Maier U, Simak R, Neuhold N, J Clin Pathol 1995 48 314 317 10.1136/jcp.48.4.314 7615848
5. Ancilliary methods for the detection of recurrent urothelial neoplasia. Ross J, Cohen M, Cancer 2000 90 75 86 10.1002/(SICI)1097-0142(20000425)90: 2<75::AID-CNCR2>3.0.CO;2-W 10794156
6. Diagnostic value of circulating tumor cells detection in bladder and urothelial cancer: systematic review and meta-analysis. Msaouel P, Koutsilieris M, BMC Cancer 2011 11 336 349 10.1186/1471-2407-11-336 21816094
7. Focus on urinary bladder cancer markers: a review. Ecke T, Minerva Urol Nefrol 2008 60 237 246 18923360
8. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA, King W, J Mol Diagn 2000 2 116 123 10.1016/S1525-1578(10)60625-3 11229514
9. Expression of a novel non-coding mitochondrial RNA in human proliferating cells. Villegas J, Burzio V, Villota C, Landerer E, Martinez R, Santander M, Martinez R, Pinto R, Vera MI, Boccardo E, Villa LL, Burzio LO, Nucleic Acids Res 2007 35 7336 7347 10.1093/nar/gkm863 17962305
10. Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells. Burzio VA, Villota C, Villegas J, Landerer E, Boccardo E, Villa LL, Martínez R, Lopez C, Gaete F, Toro V, Rodriguez X, Burzio LO, Proc Natl Acad Sci USA 2009 106 9430 9434 10.1073/pnas.0903086106 19470459
11. Expression of mitocondrial ncRNAs is modulated by high risk HPV oncogenes. Villota C, Campos A, Vidaurre S, Oliveira-Cruz L, Boccardo E, Burzio VA, Varas M, Villegas J, Villa LL, Valenzuela PDT, Socias M, Roberts S, Burzio LO, J Biol Chem 2012 287 21303 21315 10.1074/jbc.M111.326694 22539350
12. Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells. Landerer E, Villegas J, Burzio VA, Oliveira L, Villota C, Lopez C, Restovic F, Martinez R, Castillo O, Burzio LO, Cellular Oncol 2011 34 297 305 10.1007/s13402-011-0018-8
13. A major nucleolar protein B23 as a marker of proliferation activity of human peripheral lymphocytes. Dergunova NN, Bulycheva TI, Artemenko EG, Shpakova AP, Pegova AN, Gemjian EG, Dudnik OA, Zatsepina OV, Malashenko OS, Immunol Lett 2002 83 67 72 10.1016/S0165-2478(02)00085-8 12057857
14. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, Morgan Roupret M, Eur Urol 2011 59 997 1008 10.1016/j.eururo.2011.03.017 21458150
15. Guidance for fluorescencein situhybridization testing in hematologic disorders. Wolff DJ, Bagg A, Cooley LD, Dewald GW, Hirsch BA, Jacky PB, Rao KW, Rao PN, J Mol Diagn 2007 9 134 143 10.2353/jmoldx.2007.060128 17384204
16. A comparison of cytology and fluorescencein situhybridization for the detection of urothelial carcinoma. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB, J Urol 2000 164 1768 1775 10.1016/S0022-5347(05)67104-2 11025767
17. Multitarget fluorescencein situhybridization and melanoma antigen genes analysis in primary bladder carcinoma. Kang JU, Koo SH, Jeong TE, Kwon KC, Park JW, Jeon CH, Cancer Genet Cytogenet 2006 164 32 38 10.1016/j.cancergencyto.2005. 06.006 16364760
18. Quantitative fluorescencein situhybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer. Kipp BR, Tanasescu M, Else TA, Bryant SC, Karnes RJ, Sebo TJ, Halling KC, J Mol Diagn 2009 11 148 154 10.2353/jmoldx.2009.080096 19179455
19. The urinary sediment beyond light microscopical examination. Colucci G, Floege J, Schena FP, Nephrol Dial Transplant 2006 21 1482 1485 10.1093/ndt/gfl223 16714337
20. Improved filter method for urine sediment detection of urothelial carcinoma by fluorescencein situhybridization. Meiers I, Singh H, Hossain D, Lang K, Liu L, Qian J, Verhest AP, Bostwick DG, Arch Pathol Lab Med 2007 131 1574 1579 17922595
21. Review of molecular diagnostics in multiple myeloma. Stewart AK, Fonseca R, Expert Rev Mol Diagn 2007 7 453 459 10.1586/14737159.7.4.453 17620051
22. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis. Bryce AH, Ketterling RP, Gertz MA, Lacy M, Knudson RA, Zeldenrust S, Kumar S, Hayman S, Buadi F, Kyle RA, Greipp PR, Lust JA, Russell S, Rajkumar SV, Fonseca R, Dispenzieri A, Haematologica 2009 94 380 386 10.3324/haematol. 13369 19211640
23. IFM and MAG groups. Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone. Avet-Loiseau H, Soulier J, Fermand JP, Yakoub-Agh, Leukemia 2010 24 623 628 10.1038/leu.2009.273 20072152
24. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescencein situhybridization. Pauletti G, Godolphin W, Press MF, Slamon DJ, Oncogene 1996 13 63 72 8700555
25. Fluorescentin situhybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Escudier SM, Pereira-Leahy JM, Drach JW, Weier HU, Goodacre AM, Cork MA, Trujillo JM, Keating MJ, Andreeff M, Blood 1993 81 2702 2707 7683927
26. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Hagemeijer A, Buijs A, Smit E, Janssen B, Creemers GJ, Van der Plas D, Grosveld G, Genes Chromosomes Cancer 1993 8 237 245 10.1002/gcc.2870080406 7512367
27. Miniaturized FISH for screening of onco-hematological malignancies. Zanardi A, Bandiera D, Bertolini F, Corsini CA, Gregato G, Milani P, Barborini E, Carbone R, Biotechniques 2010 49 497 504 10.2144/000113445 20615202
28. Chronic lymphocytic leukemia FISH impact on diagnosis panel. Nelson B, Gupta R, Dewald G, Paternoster S, Rosen S, Peterson L, American J Clinical Pathol 2007 128 323 332 10.1309/21TN2RUWKR827UW2
29. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Jiang F, Caraway NP, Nebiyou Bekele B, Zhang HZ, Khanna A, Wang H, Li R, Fernandez RL, Zaidi TM, Johnston DA, Katz RL, Clin Cancer Res 2005 11 5417 5424 10.1158/1078-0432.CCR-04-2087 16061856
30. A novel multiple FISH array for the detection of genetic aberrations in cancer. Li R, Liu Z, Fan T, Jiang F, Lab Invest 2006 86 619 627 16518404